Better tests for diagnosing heparin-induced thrombocytopenia
Improved diagnostics for heparin induced thrombocytopenia
This study is working on a new way to quickly and accurately diagnose heparin-induced thrombocytopenia (HIT) in patients who are receiving heparin, so they can get the right treatment faster and stay safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11029546 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis of heparin-induced thrombocytopenia (HIT), a serious condition that can occur in patients receiving heparin, an anticoagulant. The current diagnostic methods are complex and limited, leading to delays in treatment and increased risks for patients. The researchers aim to develop a new molecular sensor that detects the mechanical forces generated by platelets, which could serve as a more rapid and accurate diagnostic tool for HIT. By streamlining the diagnostic process, this research seeks to enhance patient safety and treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are receiving heparin and are at risk of developing heparin-induced thrombocytopenia.
Not a fit: Patients who are not receiving heparin or those who have already been diagnosed with HIT may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to quicker and more accurate diagnoses of heparin-induced thrombocytopenia, reducing complications and improving patient care.
How similar studies have performed: Previous research has shown promise in using mechanical biomarkers for platelet activity, suggesting that this approach could be effective.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Salaita, Khalid S. — Emory University
- Study coordinator: Salaita, Khalid S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.